Published in Open Biol on June 01, 2015
Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia. Genes Dev (2016) 0.81
APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL. Leukemia (2017) 0.77
LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia. Leukemia (2016) 0.76
Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia. Blood (2017) 0.75
The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help. J Exp Med (2017) 0.75
Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia. Front Oncol (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 19.77
Angiogenesis in health and disease. Nat Med (2003) 14.02
Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell (2009) 11.65
Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature (1991) 10.30
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest (2008) 9.42
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature (2007) 9.12
An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature (1994) 8.60
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med (2003) 8.59
Acute lymphoblastic leukemia. N Engl J Med (2004) 7.83
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest (2008) 7.05
Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med (2004) 6.91
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell (2002) 6.64
The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J (1997) 6.36
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med (2002) 6.25
A fresh look at iPS cells. Cell (2009) 5.73
Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature (1995) 5.42
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol (2009) 4.89
The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell (1994) 4.58
Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo- and a Cys-His domain. Nature (1990) 4.35
Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-11. Nature (1990) 4.17
mec-3, a homeobox-containing gene that specifies differentiation of the touch receptor neurons in C. elegans. Cell (1988) 4.12
Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N Engl J Med (2004) 4.05
The LIM domain is a modular protein-binding interface. Cell (1994) 3.50
Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci U S A (1995) 3.47
Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood (2002) 3.21
Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton. J Cell Biol (1992) 3.20
Acute lymphoblastic leukemia. N Engl J Med (1998) 3.15
Recombination centres and the orchestration of V(D)J recombination. Nat Rev Immunol (2011) 3.12
The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci U S A (1991) 3.12
Two tandemly organized human genes encoding the T-cell gamma constant-region sequences show multiple rearrangement in different T-cell types. Nature (1985) 2.92
SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression. Nat Immunol (2000) 2.87
TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene (1991) 2.71
Rescue of erythroid development in gene targeted GATA-1- mouse embryonic stem cells. Nat Genet (1992) 2.66
The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci U S A (1998) 2.64
The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science (2010) 2.64
Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. Nature (1996) 2.57
Genome manipulation in embryonic stem cells. Philos Trans R Soc Lond B Biol Sci (1993) 2.50
Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci U S A (1989) 2.45
Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell (2014) 2.44
Embryonic origin of the adult hematopoietic system: advances and questions. Development (2011) 2.44
Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell (1991) 2.35
Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J (1994) 2.32
The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol (1989) 2.24
Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A (1989) 2.23
Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J (1996) 2.11
The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc Natl Acad Sci U S A (1994) 2.09
Cell competition is a tumour suppressor mechanism in the thymus. Nature (2014) 1.97
Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. Proc Natl Acad Sci U S A (1995) 1.96
The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood (2006) 1.94
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. J Clin Oncol (2007) 1.88
TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. Semin Cancer Biol (1993) 1.82
Oncogenic conversion of transcription factors by chromosomal translocations. Cell (1991) 1.80
The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. Proc Natl Acad Sci U S A (1997) 1.76
The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif. Oncogene (1990) 1.68
The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc Natl Acad Sci U S A (2000) 1.65
T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. Oncogene (1992) 1.64
A cluster of chromosome 11p13 translocations found via distinct D-D and D-D-J rearrangements of the human T cell receptor delta chain gene. EMBO J (1988) 1.63
The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood (2006) 1.63
TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Mol Cell Biol (1998) 1.49
The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice. Oncogene (1995) 1.49
The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development. Mol Cell Biol (2003) 1.44
The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development. J Mol Biol (1992) 1.38
Selection of antibodies for intracellular function using a two-hybrid in vivo system. Proc Natl Acad Sci U S A (1999) 1.38
Segmental and developmental regulation of a presumptive T-cell oncogene in the central nervous system. Nature (1990) 1.38
The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells. EMBO J (1998) 1.34
An unusual structure of a putative T cell oncogene which allows production of similar proteins from distinct mRNAs. EMBO J (1990) 1.27
NOTCH and PI3K-AKT pathways intertwined. Cancer Cell (2007) 1.26
Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice. Mol Cell Biol (2004) 1.26
T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene (1994) 1.25
Molecular dissection of a LIM domain. Mol Biol Cell (1997) 1.24
Initiation of murine embryonic erythropoiesis: a spatial analysis. Blood (1997) 1.23
A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts. Mol Cell Biol (2000) 1.22
Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex. Blood (2010) 1.20
Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis. Proc Natl Acad Sci U S A (1998) 1.20
LIM-domain-only proteins in cancer. Nat Rev Cancer (2013) 1.19
Multiple proteins binding to a GATA-E box-GATA motif regulate the erythroid Krüppel-like factor (EKLF) gene. J Biol Chem (1998) 1.15
Ectopic expression of rhombotin-2 causes selective expansion of CD4-CD8- lymphocytes in the thymus and T-cell tumors in transgenic mice. Blood (1995) 1.12
Design, production and characterization of FLIN2 and FLIN4: the engineering of intramolecular ldb1:LMO complexes. Protein Eng (2001) 1.11
MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells. J Cell Mol Med (2010) 1.10
Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia. Oncogene (1998) 1.09
scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene (1995) 1.09
A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients. Oncogene (2010) 1.08
Cysteine-rich LIM domains of LIM-homeodomain and LIM-only proteins contain zinc but not iron. Proc Natl Acad Sci U S A (1994) 1.07
Lmo2 and GATA-3 associated expression in intraembryonic hemogenic sites. Development (2000) 1.05
Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells. Cell Rep (2014) 1.04
Structure of the cysteine-rich intestinal protein, CRIP. J Mol Biol (1996) 1.03
An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions. Oncogene (2008) 1.03
Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL. J Biol Chem (1997) 1.02
Developmentally regulated and tissue specific expression of mRNAs encoding the two alternative forms of the LIM domain oncogene rhombotin: evidence for thymus expression. Oncogene (1991) 1.02
Tracking mesoderm formation and specification to the hemangioblast in vitro. Trends Cardiovasc Med (2004) 1.00
Expression of LIM protein genes Lmo1, Lmo2, and Lmo3 in adult mouse hippocampus and other forebrain regions: differential regulation by seizure activity. J Neurosci (1997) 1.00
New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. Mol Ther (2007) 1.00
Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein. J Mol Biol (2002) 0.98
The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target. Oncogene (2002) 0.98
Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction. J Biol Chem (2007) 0.96
Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia. Stem Cells (2013) 0.96
LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer. Neoplasia (2009) 0.96